The high expression levels of MYLIP and E-Cadherin (CDH1) could significantly elevate the survival rates for breast cancer patients compared with their low expression groups (p = 0.0196 for MYLIP curve, p = 0.0070 for CDH1 curve) (Figure 6B, 6C). This evidence concerns the gene MYLIP and breast cancer.